Page last updated: 2024-11-13

sansanmycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

sansanmycin: isolated from Streptomyces; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID57395472
CHEMBL ID1910804
MeSH IDM0509962

Synonyms (4)

Synonym
sansanmycin a
CHEMBL1910804
sansanmycin
dereplicator identification - sansanmycin;_sansanmycin_a
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID713895Antimycobacterial activity against Mycobacterium tuberculosis H37Rv ATCC 272942012European journal of medicinal chemistry, Mar, Volume: 49Recent advances in antitubercular natural products.
AID625489Antitubercular activity against rifampicin and isoniazid-resistant Mycobacterium tuberculosis isolate 2199 after 24 hrs by microplate alamar blue assay2011Bioorganic & medicinal chemistry letters, Nov-15, Volume: 21, Issue:22
Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
AID1181078Antibacterial activity against Mycobacterium tuberculosis H37Rv after 5 days by microplate Alamar Blue assay2014Journal of natural products, Jul-25, Volume: 77, Issue:7
NRPS substrate promiscuity leads to more potent antitubercular sansanmycin analogues.
AID1181079Antibacterial activity against Pseudomonas aeruginosa 11 after 24 hrs by microdilution test2014Journal of natural products, Jul-25, Volume: 77, Issue:7
NRPS substrate promiscuity leads to more potent antitubercular sansanmycin analogues.
AID625488Antitubercular activity against Mycobacterium tuberculosis H37Rv after 24 hrs by microplate alamar blue assay2011Bioorganic & medicinal chemistry letters, Nov-15, Volume: 21, Issue:22
Synthesis and in vitro antitubercular evaluation of novel sansanmycin derivatives.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (13.33)29.6817
2010's11 (73.33)24.3611
2020's2 (13.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.57

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.57 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index5.34 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.57)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]